已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

A case with good response to belimumab for lupus nephritis complicated by IgG4-related disease

贝里穆马布 医学 狼疮性肾炎 蛋白尿 肾活检 高丙种球蛋白血症 泼尼松龙 内科学 系统性红斑狼疮 胃肠病学 免疫学 托珠单抗 糖皮质激素 皮肤病科 血清学 抗体 活检 疾病 B细胞激活因子 B细胞
作者
Motohisa Yamamoto,Satsuki Aochi,Chisako Suzuki,Seiji Nakamura,Rieko Murakami,Yoshihide Ogawa,Hiroki Takahashi
出处
期刊:Lupus [SAGE]
卷期号:28 (6): 786-789 被引量:15
标识
DOI:10.1177/0961203319840430
摘要

Immunoglobulin (Ig)G4-related disease (IgG4-RD) is an unusual complication of systemic lupus erythematosus (SLE). We report a case in which belimumab proved efficacious for not only SLE, but also IgG4-RD. A 58-year-old Japanese woman had suffered from photodermatosis and erythema on the limbs for 20 years. She presented in slight fever and fatigue since 2016. Laboratory data showed hypergammaglobulinemia, proteinuria and positive results for anti-nuclear antibody and anti-double-stranded DNA antibody. Furthermore, elevated levels of serum IgG4 were detected. Contrast-enhanced computed tomography disclosed multiple areas of poor enhancement in the kidneys. The patient was diagnosed with lupus nephritis and IgG4-RD from renal biopsy. Treatment was started with prednisolone at 40 mg/day and mycophenolate mofetil. Proteinuria and serological findings improved initially, but tapering the dose of glucocorticoid proved difficult. After treatment was started with belimumab, clinical symptoms and proteinuria resolved completely. The dose of glucocorticoid was successfully tapered and serum concentration of IgG4 fell further. This appears to represent the first report of a case in which both SLE and IgG4-RD were effectively treated using belimumab.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
江峰应助科研通管家采纳,获得10
刚刚
爱静静应助科研通管家采纳,获得10
刚刚
江峰应助科研通管家采纳,获得10
刚刚
爱静静应助科研通管家采纳,获得10
1秒前
江峰应助科研通管家采纳,获得10
1秒前
咚咚应助冲浪男孩226采纳,获得10
1秒前
科研通AI2S应助科研通管家采纳,获得10
1秒前
SciGPT应助科研通管家采纳,获得10
1秒前
1秒前
小马甲应助科研通管家采纳,获得10
1秒前
今后应助科研通管家采纳,获得10
1秒前
CodeCraft应助科研通管家采纳,获得10
1秒前
roy完成签到,获得积分10
2秒前
TT完成签到 ,获得积分10
3秒前
阿池发布了新的文献求助10
8秒前
8秒前
wasttt发布了新的文献求助10
10秒前
15秒前
16秒前
18秒前
Lee发布了新的文献求助10
21秒前
博洋发布了新的文献求助10
23秒前
哈哈发布了新的文献求助10
23秒前
日常卖命完成签到 ,获得积分10
23秒前
啤酒大王发布了新的文献求助20
23秒前
壮观季节关注了科研通微信公众号
24秒前
团结友爱完成签到,获得积分10
24秒前
科研通AI2S应助Lee采纳,获得10
31秒前
万能图书馆应助宋贺贺采纳,获得10
31秒前
巫马尔槐完成签到,获得积分10
33秒前
36秒前
博洋完成签到,获得积分10
37秒前
丘比特应助巫马书桃采纳,获得10
37秒前
xzy998应助专一的小海豚采纳,获得10
40秒前
41秒前
壮观季节发布了新的文献求助10
41秒前
45秒前
ran完成签到,获得积分10
47秒前
所所应助哈哈采纳,获得10
48秒前
52秒前
高分求助中
Licensing Deals in Pharmaceuticals 2019-2024 3000
Cognitive Paradigms in Knowledge Organisation 2000
Effect of reactor temperature on FCC yield 2000
How Maoism Was Made: Reconstructing China, 1949-1965 800
Introduction to Spectroscopic Ellipsometry of Thin Film Materials Instrumentation, Data Analysis, and Applications 600
Promoting women's entrepreneurship in developing countries: the case of the world's largest women-owned community-based enterprise 500
Shining Light on the Dark Side of Personality 400
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3310848
求助须知:如何正确求助?哪些是违规求助? 2943666
关于积分的说明 8515977
捐赠科研通 2619022
什么是DOI,文献DOI怎么找? 1431761
科研通“疑难数据库(出版商)”最低求助积分说明 664472
邀请新用户注册赠送积分活动 649732